Search
Nasus Pharma Ltd
NSRXAdd to Watchlist
3.515USD
+0.015+0.43%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
41.16MMarket Cap
LossP/E TTM
Nasus Pharma Ltd Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-0.73
-332.33%
Analyst Rating
BUY
2026-07-01
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Nasus Pharma Ltd?
According to Nasus Pharma Ltd's FY2025 earnings report, its current assets were 4.86M, with a year-on-year change of 962.36.
What are the total assets of Nasus Pharma Ltd?
According to Nasus Pharma Ltd's FY2025 earnings report, its total assets of Nasus Pharma Ltd were 5.00M, with a year-on-year change of 597.91.
What are the total liabilities of Nasus Pharma Ltd?
According to Nasus Pharma Ltd's FY2025 earnings report, its total liabilities of Nasus Pharma Ltd were 2.24M, with a year-on-year change of -43.09.
What is the total equity of Nasus Pharma Ltd?
According to Nasus Pharma Ltd's FY2025 earnings report, its total equity of Nasus Pharma Ltd was 2.77M, with a year-on-year change of 186.18.
What is the net financing of Nasus Pharma Ltd?
According to Nasus Pharma Ltd's FY2025 earnings report, its net financing of Nasus Pharma Ltd was 8.92M, with a year-on-year change of 1058.44.
What is the Earnings Per Share (EPS) of Nasus Pharma Ltd?
According to Nasus Pharma Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -0.73, with a year-on-year change of -332.33.
What is the Return on Assets (ROA) of Nasus Pharma Ltd?
According to Nasus Pharma Ltd's FY2025 earnings report, its Return on Assets (ROA) was -202.94, with a year-on-year change of 24.09.
What is the operating profit of Nasus Pharma Ltd?
According to Nasus Pharma Ltd's FY2025 earnings report, its operating profit was -4.90M, with a year-on-year change of -354.92.